Results 31 to 40 of about 2,996,041 (224)

Neuromyelitis optica spectrum disorder: importance and difficulties of differential diagnosis with multiple sclerosis

open access: yesЛечащий Врач, 2021
Neuromyelitis optica spectrum disorder is a group of rare and severe immune-mediated neurological conditions. We have discussed with Maria Davydovskaya, the Deputy Chief External Experts in Neurology, the key differences of this disease from multiple ...
M. V. Davydovskaya
doaj   +1 more source

Concentrations of B cell-activating factor, aquaporin-4 antibody and brain-derived neurotrophic factor in neuromyelitis optica spectrum disorder

open access: yesTürk Biyokimya Dergisi, 2022
To explore the correlations of B cell-activating factor (BAFF), aquaporin-4 antibody (AQP4-Ab) and brain-derived neurotrophic factor (BDNF) with the severity of neuromyelitis optica spectrum disorder (NMOSD).
Li Suping   +5 more
doaj   +1 more source

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate [PDF]

open access: yesBMC Neurology, 2014
To review our experience using methotrexate as a single long-term immunosuppressant (IS) therapy in neuromyelitis optica/neuromyelitis optica spectrum disorders (NMO/NMOSD).We performed a retrospective chart review of all patients with a diagnosis of NMO/NMOSD, supported by a positive NMO-IgG testing, who were treated with methotrexate. A paired sample
Ramanathan, Ramnath Santosh   +2 more
openaire   +2 more sources

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients [PDF]

open access: yes, 2012
BACKGROUND: The diagnostic and pathophysiological relevance of antibodies to aquaporin-4 (AQP4-Ab) in patients with neuromyelitis optica spectrum disorders (NMOSD) has been intensively studied. However, little is known so far about the clinical impact of
Jarius Sven   +269 more
core   +2 more sources

Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab [PDF]

open access: yes, 2009
In neuromyelitis optica (NMO), the monoclonal B-cell antibody rituximab is a therapeutic option. Little is known about the course of NMO and the safety of rituximab during pregnancy.
Hohlfeld, R.   +4 more
core   +1 more source

Neuromyelitis optica spectrum disorder: an overview [PDF]

open access: yesActa Neurobiologiae Experimentalis, 2020
Neuromyelitis optica also known as Devic's syndrome is a rare autoimmune disorder that predominantly targets the optic nerves and the spinal cord. It is a debilitating disorder that damages a person's health. Initially it was considered as a variant of multiple sclerosis (MS).
Ramakrishnan, Pooja   +1 more
openaire   +2 more sources

Neuromyelitis optica spectrum disorder with AQP4‐IgG presenting as area postrema syndrome and progressing to myelitis: A rare case report

open access: yesClinical Case Reports, 2023
Key Clinical Message Neuromyelitis optica spectrum disorders can less commonly present with area postrema syndrome progressing to myelitis. Management involves intravenous glucocorticoids, plasma exchange, and preventive immunotherapy.
Preethi Jagannath   +6 more
doaj   +1 more source

Central Sleep Apnea Syndrome Can Complicate Neuromyelitis Optica Spectrum Disorder: A Case Report

open access: yesFrontiers in Pediatrics, 2020
Neuromyelitis optica spectrum disorder is a rare, relapsing autoimmune disease of the central nervous system. Various initial presentations can delay diagnosis and treatment.
Céline Morelli   +10 more
doaj   +1 more source

Neuromyelitis optica spectrum disorder with increased aquaporin-4 microparticles prior to autoantibodies in cerebrospinal fluid: a case report

open access: yesJournal of Medical Case Reports, 2019
Background Neuromyelitis optica spectrum disorders are severe autoimmune inflammatory diseases of the central nervous system associated with the presence of immunoglobulin G antibodies against the water channel protein aquaporin-4.
Susanne Bejerot   +6 more
doaj   +1 more source

Aquaporin-4-IgG Positive Neuromyelitis Optica Spectrum Disorder from Ethiopia: A Case Report [PDF]

open access: yes, 2020
BACKGROUND: Neuromyelitis Optica spectrum disorder is an inflammatory disorder affecting the central nervous system), most commonly attacking the spinal cord or optic nerves. Limited cases of neuromyelitis optica have been reported in east Africa.
Dereje Melka, null Dereje Melka
core   +1 more source

Home - About - Disclaimer - Privacy